Evidence map›Paper›PMID 37698610›Full record

ArticleApplied microbiology and biotechnology2023

Stepwise genetic modification for efficient expression of heterologous proteins in Aspergillus nidulans.

Qin Yan, Laichuang Han, Zhongmei Liu, Shengmin Zhou, Zhemin Zhou

Abstract read
PubMed Publisher
In one paragraph

Article in Applied microbiology and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Qin YanSchool of Biotechnology, Jiangnan University, Wuxi, Jiangsu, China.
Laichuang HanSchool of Biotechnology, Jiangnan University, Wuxi, Jiangsu, China.
Zhongmei LiuSchool of Biotechnology, Jiangnan University, Wuxi, Jiangsu, China.
Shengmin ZhouState Key Laboratory of Bioreactor Engineering, School of Biotechnology, East China University of Science and Technology, Shanghai, China. zhoushengmin@ecust.edu.cn.
Zhemin ZhouSchool of Biotechnology, Jiangnan University, Wuxi, Jiangsu, China. zhmzhou@jiangnan.edu.cn.ORCID http://orcid.org/0000-0003-0604-1885
Jiangnan University · CNEast China University of Science and Technology · CN

Funding

China Postdoctoral Science Foundation 2021M701461National Natural Science Foundation of China 32201034
6 · The paper itself

Abstract

Filamentous fungi are widely used in food fermentation and therapeutic protein production due to their prominent protein secretion and post-translational modification system. Aspergillus nidulans is an important model strain of filamentous fungi, but not a fully developed cell factory for heterologous protein expression. One of the limitations is its relatively low capacity of protein secretion. To alleviate this limitation, in this study, the protein secretory pathway and mycelium morphology were stepwise modified. With eGFP as a reporter protein, protein secretion was significantly enhanced through reducing the degradation of heterologous proteins by endoplasmic reticulum-associated protein degradation (ERAD) and vacuoles in the secretory pathway. Elimination of mycelial aggregation resulted in a 1.5-fold and 1.3-fold increase in secretory expression of eGFP in typical constitutive and inducible expression systems, respectively. Combined with these modifications, high secretory expression of human interleukin-6 (HuIL-6) was achieved. Consequently, a higher yield of secretory HuIL-6 was realized by further disruption of extracellular proteases. Overall, a superior chassis cell of A. nidulans suitable for efficient secretory expression of heterologous proteins was successfully obtained, providing a promising platform for biosynthesis using filamentous fungi as hosts. KEY POINTS: • Elimination of mycelial aggregation and decreasing the degradation of heterologous protein are effective strategies for improving the heterologous protein expression. • The work provides a high-performance chassis host △agsB-derA for heterologous protein secretory expression. • Human interleukin-6 (HuIL-6) was expressed efficiently in the high-performance chassis host △agsB-derA.

Indexed as

Aspergillus nidulansGene ExpressionInterleukin-6Recombinant ProteinsEndoplasmic Reticulum-Associated DegradationGreen Fluorescent ProteinsHumansMyceliumSecretory Pathwayenhanced green fluorescent proteinGreen Fluorescent ProteinsInterleukin-6Recombinant ProteinsAspergillus nidulansHuman interleukin-6Mycelial morphologyProtein secretory pathwaySuperior chassis cell

Identifiers

PMID37698610
OpenAlexW4386624492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.